MSKCC — New York, New York

MSKCC is a clinical research site located in New York, New York, United States 10065.

Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

MSKCC has participated in 17 clinical trials with 6 currently active.

Therapeutic areas: Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS), Myelodysplastic Syndromes (MDS), Amyloidosis.

Sponsors: Institut de Recherches Internationales Servier, Millennium Pharmaceuticals, Inc., BioNTech Research & Development, Inc..

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MSKCC?

MSKCC has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MSKCC conducted?

MSKCC has 17 clinical trials on record, with 6 currently active. Their work covers Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS), Myelodysplastic Syndromes (MDS), Amyloidosis.

Is MSKCC accredited by Crixeo Health?

MSKCC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MSKCC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.